SOFIA 6F Catheter

K150366 · MicroVention, Inc. · DQY · Mar 27, 2015 · Cardiovascular

Device Facts

• Record ID: K150366
• Device Name: SOFIA 6F Catheter
• Applicant: MicroVention, Inc.
• Product Code: DQY · Cardiovascular
• Decision Date: Mar 27, 2015
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1250
• Device Class: Class 2

Intended Use

The SOFIA PLUS/Distal Access Catheters are indicated for general intravascular use, including the neuro and peripheral vasculature. It can be used to facilitate introduction of diagnostic and therapeutic agents. It is not intended for use in coronary arteries.

Device Story

Single-lumen, flexible catheter; coil and braid reinforcement; steam-shapeable distal segment; hydrophilic coating; radiopaque marker for fluoroscopic visualization. Used in neuro and peripheral vasculature; operated by physicians. Facilitates delivery of diagnostic and therapeutic agents. Provides access to target sites in tortuous anatomy. Benefits patient by enabling minimally invasive intravascular procedures.

Clinical Evidence

Bench testing only. Testing included simulated use, dimensional/physical attributes, kink resistance, tip shapeability, radiopacity, hub performance (ISO 594-2), coating durability/lubricity, torque strength, flexural fatigue, surface contamination, flow rate, burst pressure, and leakage. Biocompatibility testing (ISO 10993) confirmed non-cytotoxic, non-irritant, non-hemolytic, and non-pyrogenic status. No clinical data provided.

Technological Characteristics

Single-lumen catheter; polyurethane elastomer, Pebax, polyamide, stainless steel braid/coil, PTFE, polyolefin elastomer construction. Hydrophilic coating (Hydak). Radiopaque platinum/iridium marker. 6F size. Ethylene Oxide sterilization. Complies with ISO 594-2 (luer), ISO 10555-1 (pressure/leakage), and ISO 10993 (biocompatibility).

Indications for Use

Indicated for general intravascular use in neuro and peripheral vasculature to facilitate introduction of diagnostic and therapeutic agents. Not for use in coronary arteries.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

• SOFIA Distal Access Catheter (K142014/K131482)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

March 27, 2015

Microvention, Inc. Ms. Naomi Gong Sr. Regulatory Affairs Project Manager 1311 Valencia Ave Tustin, California 92780

Re: K150366

Trade/Device Name: Sofia 6F PLUS/Distal Access Catheters Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DQY, DQO Dated: February 11, 2015 Received: February 12, 2015

Dear Ms. Gong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Carlos L. Pena -S

Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K150366

Device Name SOFIA PLUS/Distal Access Catheter

Indications for Use (Describe)

The SOFIA PLUS/Distal Access Catheters are indicated for general intravascular use, including the neuro and peripheral vasculature. It can be used to facilitate introduction of diagnostic and therapeutic agents. It is not intended for use in coronary arteries.

Type of Use (Select one or both, as applicable)

| <label><input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D)</label> |
|-------------------------------------------------------------------------------------------------|
| <label><input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C)</label> |

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

| <b>510(k) Summary</b> | |
|-----------------------|------------------------------------------------------------------------|
| Trade Name: | SOFIA™ PLUS Catheter<br>SOFIA™ Distal Access Catheter |
| Generic Name: | Percutaneous Catheter |
| Classification: | Class II, 21 CFR 870.1250 (DQY), 21CFR 870.1200 (DQO) |
| Submitted By: | MicroVention, Inc<br>1311 Valencia Avenue<br>Tustin, California U.S.A. |
| Contact: | Naomi Gong |
| Date: | 2015 February 11 |
| Predicate Device: | SOFIA Distal Access Catheter (K142014/K131482) |

### Device Description:

The SOFIA PLUS/Distal Access Catheters are a single-lumen, flexible catheter designed with coil and braid reinforcement. The distal segment is steam-shapeable and it has a hydrophilic coating for navigation through the vasculature. The radiopaque marker is located at the distal end of the catheter for visualization under fluoroscopy. An introducer sheath and shaping mandrel are also provided.

### Indications For Use:

The SOFIA PLUS/Distal Access Catheters are indicated for general intravascular use, including the neuro and peripheral vasculature. It can be used to facilitate introduction of diagnostic and therapeutic agents. It is not intended for use in coronary arteries.

| | SOFIA Distal Access Catheter<br>(predicate) | SOFIA PLUS/Distal Access<br>Catheter |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|
| Intended Use | Intended for general intravascular use, including the neuro and peripheral vasculature.<br>It can be used to facilitate the introduction of diagnostic and therapeutic agents. It is not intended for use in coronary arteries. | Same |
| Material<br>Catheter Body | Outer layer of polyurethane elastomer (Polyblend and Pellethane), polyether block amide (Pebax) and polyamide (Grilamid); inner layer of stainless steel braid/coil, PTFE and polyolefin elastomer | Same |
| Marker | Platinum/Iridium | |
| Hub | Nylon | |
| Strain Relief | Polyurethane | |
| Introducer | Pebax | |
| Shaping Mandrel | Stainless steel | |
| Catheter size | 5 F | 6F |
| ID | 0.055 inch (1.4 mm) | 0.070 inch (1.78 mm) |
| OD | 0.068 inch (1.7 mm) | 0.0825 inch (2.1 mm) |
| Effective Length | 115-125 cm | 115-135 cm |

### Technological Comparison:

{4}------------------------------------------------

| | SOFIA Distal Access Catheter<br>(predicate) | SOFIA PLUS/Distal Access<br>Catheter |
|-------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------|
| Coating | Hydrophilic coating<br>(Hydak® - same) | Same |
| Tip Configuration | Steam shapeable by user | Same |
| Guidewire Compatibility | 0.035 inch | Same |
| Accessories | Introducer sheath and shaping mandrel | Same |
| Method of Supply | Sterile and single use | Same |
| Sterilization Method | Ethylene Oxide | Same |
| Packaging Configuration | Catheter placed into a HDPE dispenser tube.<br>Dispenser tube, introducer and shaping mandrel<br>placed on a polyethylene packaging card that is<br>inserted into a Tyvek® pouch. Pouch and IFU<br>placed in bleached sulfate carton box. | Same |

# Verification and Test Summary:

| Bench Testing | | |
|---------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|
| Test | Results | Conclusions |
| Simulated Use | Test articles achieved a rating ≥ 3 for<br>preparation/ease of assembly, introducer<br>sheath interaction, introducer peel away,<br>tracking with guidewire/microcatheter,<br>microcatheter/guidewire lockup, lubricity<br>and durability of hydrophilic coating,<br>microcatheter/ guidewire removal,<br>removal/ aspiration of clot, mechanical<br>clot retriever and stent delivery with no<br>particles | Device performs as intended<br>under simulated use<br>conditions |
| Equipment Interface | Test articles compatible with 0.035-inch<br>guidewire, 7F or larger guide<br>catheter/guiding sheath, common RHVs<br>using insertion tool, stopcocks and ≤<br>0.027-inch microcatheters | Device compatible with<br>recommended accessories<br>commonly used in<br>intravascular procedures |
| Dimensional and Physical Attributes | Test articles met the specified dimensional<br>requirements for catheter OD, catheter ID,<br>overall working length, length of distal<br>section, length of distal tip to marker band<br>and total length of hub/strain relief | Device met established<br>dimensional and physical<br>specifications |
| Kink Resistance | No kinks at 1 cm, 4 cm, 12 cm and 25 cm<br>from distal tip when wrapped around<br>0.025, 0.030, 0.040-inch pin gauges<br>No kinks noted during simulated use<br>testing | Device resistant to kinking<br>around small radii turns |
| Tip Shapeability | Tip angle of test article equivalent to<br>competitive devices after steam shaping<br>using mandrel with an angle of<br>approximately 90° | Shapeability of distal tip after<br>steam shaping – for reference |
| Radio Detectability | Distal marker band visible under<br>fluoroscopy<br>(Prior test data from predicate device) | Device radiopacity equivalent<br>to or better than predicate and<br>competitive devices |
| Gauging (ISO 594-2) | Gauging pin and hub align in limit planes<br>(Prior test data from predicate device) | Device hub meets the<br>requirements of ISO 594-2 |
| Bench Testing | | |
| Test | Results | Conclusions |
| Separation Force (ISO 594-2) | Mating parts separation force greater than 25 N (Prior test data from predicate device) | Device hub meets the requirements of ISO 594-2 |
| Unscrewing Torque (ISO 594-2) | Test article luer remains attached after applying an unscrewing torque not less than 0.02 Nm for a minimum of 10 seconds (Prior test data from predicate device) | Device hub meets the requirements of ISO 594-2 |
| Stress Cracking (ISO 594-2) | No stress cracks on test article hub (Prior test data from predicate device) | Device hub meets the requirements of ISO 594-2 |
| Ease of Assembly (ISO 594-2) | Components fit together securely with no resistance observed between test article luer and reference fitting (Prior test data from predicate device) | Device hub meets the requirements of ISO 594-2 |
| Resistance to Overriding (ISO 594-2) | Test article luer does not override reference fitting threads (Prior test data from predicate device) | Device hub meets the requirements of ISO 594-2 |
| Durability/Lubricity of Hydrophilic Coating | Test article achieved a rating of $\geq$ 3 during simulated use testing for coating durability and lubricity. | Device tracks easily with no coating cracking or separation |
| Catheter Stiffness | Device stiffness equivalent to predicate and competitive devices | Device tracks in tortuous anatomy while advancing to target site |
| Torque Strength | No catheter breakage after 50 rotations | Device torque strength same as predicate device |
| Catheter Flexural Fatigue | No flexural fatigue following repeated bending during simulated use testing and repeated hoop stress following pressure and air aspiration testing | Device integrity suitable for intended clinical use |
| Surface Contamination | Test article free from surface contaminants from uncured coating surface particulates > 0.02 mm2, embedded particulates<br>Distal tip smooth and tapered | Device integrity suitable for intended clinical use |
| Force at Break (Distal and Hub) | PTFE inner layer not delaminated<br>Catheter force at break $\geq$ 3.37 lbf for distal section and hub/catheter junction | Tensile strength test results equivalent to predicate and competitive devices |
| Flow Rate | Flow rate at 100 psi and 300 psi with diagnostic agents (e.g., saline, contrast media) equivalent to or better than competitive devices | Device meets specified requirements for delivery of diagnostic agents |
| Static Burst Pressure | No damage of pressurized catheter at 46 psi | Device integrity suitable for intended clinical use and met requirements of ISO 10555-1 |
| Fluid Leakage at > 46 psi | No liquid leakage from hub and catheter shaft at 46 psi for 30 seconds | Device integrity suitable for intended clinical use and met requirements of ISO 10555-1 |
| Air Leakage | No air leakage at hub into syringe for 15 seconds | Device integrity suitable for intended clinical use and met requirements of ISO 10555-1 |
| Dynamic Burst | Test articles did not burst at or below 300 psi | Device met labeled maximum infusion pressure of 300 psi |
| Particulate Test | Less than 25 particles greater than 10 microns per ml volume and less than 3 particles less than 25 microns per ml volume | Device met specifications for maximum allowable particles |

{5}------------------------------------------------

{6}------------------------------------------------

| | | | | Note: Biocompatibility was prior test data from predicate device. | |
|--|--|--|--|-------------------------------------------------------------------|--|
| | | | | | |

| Biocompatibility | Result | Conclusions |
|------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------|
| Cytotoxicity (ISO 10993-5)<br>- MEM elution assay | Cell culture treated with test article<br>exhibited slight reactivity (Grade 1) | Non-cytotoxic |
| Sensitization/Irritation (ISO 10993-10)<br>- Guinea pig maximization sensitization | Extracts of the test article elicited no<br>reaction at the challenge (0%<br>sensitization) following the induction<br>phase (Grade 1). | Weak allergic potential<br>or sensitizing capacity |
| Sensitization/Irritation (ISO 10993-10)<br>- Intracutaneous reactivity | Extracts of the test article did not<br>show a significantly greater<br>biological reaction than the sites<br>injected with the control article | Non-irritant |
| Hemocompatibility – Rabbit Blood Direct and<br>Indirect Contact (ISO 10993-4) | The hemolysis index was 0.13%<br>(direct contact) and 0.0% (indirect<br>contact) | Non-hemolytic |
| Hemocompatibility – Unactivated Partial<br>Thromboplastin Time Assay Direct Contact (ISO<br>10993-4) | No statistically significant difference<br>found between the Unactivated<br>Partial Thromboplastin Time (UPTT)<br>of the plasma exposed to the test<br>article and that of the plasma exposed<br>to either the negative control or the<br>untreated control | No effect on<br>coagulation |
| Hemocompatibility - Complement Activation<br>Assay (ISO 10993-4) | C3a and SC5b-9 levels ≤ negative<br>and untreated controls | No effect on<br>complement activation |
| Hemocompatibility - Thrombogenicity Study in<br>Dogs (ISO 10993-4) | Minimal thrombosis observed with a<br>Grade 0 in two out of two test sites<br>and two out of two control sites | No significant<br>thrombosis |
| Systemic Toxicity - Systemic Injection Test<br>(ISO 10993-11) | Extracts of test article did not induce<br>a significantly greater biological<br>reaction than the control extracts<br>when injected in Swiss Albino mice | No toxic effects |
| Systemic Toxicity - Rabbit Pyrogen Test (ISO<br>10993-11) | The temperature increases<br>(maximum) was 0.03°C from<br>baseline | Non-pyrogenic |

### Summary of Substantial Equivalence:

The data presented in this submission demonstrates the technological similarity and equivalency of the SOFIA PLUS/Distal Access Catheter when compared with the predicate device, SOFIA Distal Access Catheter (K142014/K131482).

The devices,

- " Have the same intended use,
- Use the same operating principle, ■
- Incorporate the same basic design,
- . Are packaged and sterilized using same methods.

In summary, the SOFIA PLUS/Distal Access Catheter described in this submission is substantially equivalent to the predicate device.